Pharmaron Beijing Co. Ltd. Announces Date for First Extraordinary General Meeting of 2025
Pharmaron Beijing Co. Ltd. will hold an extraordinary general meeting on December 18, 2025, in Beijing, China. Shareholders will vote on key resolutions, including the by-election of an independent non-executive Director and amendments to various management policies. The announcement was made via the Hong Kong Stock Exchange's Issuer Information Service.
Pharmaron Beijing Co. Ltd. will hold an extraordinary general meeting in Beijing, China, on December 18, 2025. Shareholders will consider and vote on several key resolutions, including the by-election of an independent non-executive Director of the third session of the Board, amendments to the Related Party/Connected Transactions Management Policy, amendments to the External Guarantee Management Policy, amendments to the Independent Non-executive Directors Working Policy, and amendments to the External Investment Management Policy. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharmaron Beijing Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251127-11930111), on November 27, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
